We followed the staining method of mMDSCs described by Kitano and colleagues showing that peripheral mMDSC proportion correlated with overall survival in melanoma patients treated with ipilimumab (monoclonal antibody against CTLA-4) [21]. The gene discussed is CTLA4; the disease is melanoma.